JPRN-UMIN000002784招募中未知
The effect of maxacalcitol on cardiovascular disesase in hemodialysis patients - MAX study
Department of Medicine and Clinical Science, Kyushu University0 个研究点目标入组 52 人开始时间: 2009年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Post history of intravenous vitamin D therapy Post history of cicalcet HCl treatment Post history of peritoneal dialysis or kidney transplantion Pregnant woman Post history of severe cardiovascular disease
研究者
相似试验
已完成
不适用
Cardiovascular effects of medical (ie use of calcimimetics) vs surgical parathyroidectomy in dialysis of patients. A prospective randomised trialISRCTN71926161Record Provided by the NHSTCT Register - 2006 Update - Department of Health50
进行中（未招募）
不适用
EFFECT OF PARICALCITOL ON BLOOD VESSELS.Enfermedad Renal crónica, estadío VDEUCTR2011-002554-30-ESFundación Renal Jaume Arnó
招募中
3 期
The cardiovascular safety of efficacy cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in participants established cardiovascular diseasecardiovascular diseaseNL-OMON55925ovo Nordisk160
已完成
3 期
Evaluation of the Effect of Calcitriol on the Percutaneous Coronary InterventioIRCT20151227025726N10Shahid Beheshti University of Medical Sciences72
进行中（未招募）
1 期
The effect of the drug etelcalcetide on heart muscle enlargement in hemodialysis patients - a randomized, controlled trialEUCTR2017-000222-35-ATMedical University of Vienna